Skip to main content

Specialty Pharmacy

  • Walgreens collaborates with NMAC in expanding pneumococcal vaccine reach across HIV patients

    DEERFIELD, Ill. — In collaboration with the National Minority AIDS Council, Walgreens is furthering its commitment to improve HIV treatment outcomes for African Americans living with HIV by deepening pharmacists’ training and expanding access to the pneumococcal vaccination specifically indicated for persons living with HIV as incidents of flu and pneumonia rise, the retailer announced Tuesday.

  • Study: Daily aspirin use may reduce risk of ovarian cancer by 20%

    ROCKVILLE, Md. — Women who take aspirin daily may reduce their risk of ovarian cancer by 20%, according to a study by scientists at the National Cancer Institute, part of the National Institutes of Health. 

    The study was published Feb. 6 in the Journal of the National Cancer Institute.

  • Q&A: Taking the pulse with Mitch Rothschild of Vitals

    Selecting a doctor can be a frustrating process filled with too many unknowns, especially in today’s evolving landscape. Looking to help patients take the guesswork out of finding the ideal doctor, Vitals has developed online tools at Vitals.com to give patients visibility into quality, cost and availability.

  • Q&A: Genetic profiling with Dr. Anita Goel of Nanobiosym

    A new and possibly transformative technology for rapidly diagnosing and evaluating patients based on their specific genetic profile may soon begin appearing at retail pharmacies and clinics, giving pharmacists and clinicians another tool for advancing patient health outcomes and their own practice capabilities.

    Dr. Anita Goel, M.D., Ph.D.

  • Diplomat discusses role of patient advocacy on Pharmacy Podcast

    FLINT, Mich. — Diplomat on Wednesday released its second episode in partnership with Pharmacy Podcast. The new installment discusses the role of patient advocacy within the specialty pharmacy field. Diplomat’s manager of patient advocacy, Brenda Hawkes, joins Pharmacy Podcast’s Todd Eury for this conversation. 

  • CVS recognized for its new Specialty Connect program by the Pharmacy Benefit Management Institute

    WOONSOCKET, R.I. — CVS Caremark was awarded the 2014 Rx Benefit Innovation Award by the Pharmacy Benefit Management Institute on Tuesday, the company reported. The award recognizes the company's new Specialty Connect program, which was developed by CVS Caremark to improve access, quality of care and convenience for specialty pharmacy patients.

  • Chiesi Farmaceutici S.p.A. acquires specialty pharmaceutical company Cornerstone Therapeutics

    CARY, N.C. — Cornerstone Therapeutics, a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets, on Monday announced that its stockholders have approved, at a special stockholder meeting, the previously announced merger agreement, under which Chiesi Farmaceutici S.p.A. will acquire all of the outstanding common shares of Cornerstone for $9.50 per share in cash.

  • PhRMA partners with NIH on drug development

    WASHINGTON — The Pharmaceutical Research and Manufacturers of America on Tuesday announced a partnership with the National Institutes of Health that will help spur drug development, the association stated. 

    The Accelerating Medicines Partnership — an initiative of NIH, several non-profit disease foundations, 10 biopharmaceutical companies and PhRMA — aims to transform the current model for developing new diagnostics and treatments by joining forces to identify and validate promising biological targets of disease. 

X
This ad will auto-close in 10 seconds